BackAVEO Pharmaceuticals Overview

AVEO Pharmaceuticals Minority Interest

Track AVEO Pharmaceuticals's minority interest ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer average / median

Loading

AVEO Pharmaceuticals Minority Interest History

Loading

AVEO Pharmaceuticals vs. peers: Minority Interest Comparison

Loading

AVEO Pharmaceuticals Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AVEO Pharmaceuticals (AVEO) FAQ

AVEO Pharmaceuticals posts a minority interest of $0 as of September 2022. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, AVEO Pharmaceuticals's minority interest was $0. The latest reading is $0 (period ending September 2022). Use the history and growth charts on this page for a longer lookback.

Minority Interest is one piece of AVEO Pharmaceuticals's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AVEO's minority interest usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; AVEO Pharmaceuticals's other metric pages and overview cover the third.

Judging AVEO Pharmaceuticals against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in minority interest easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.